Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Dec 1;196(11):1484-1488.
doi: 10.1164/rccm.201702-0399LE.

Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease

Surya P Bhatt  1 , Gonzalo Vegas-Sánchez-Ferrero  2 , Farbod N Rahaghi  2 , Erick S MacLean  2 , German Gonzalez-Serrano  3 , Carolyn E Come  2 , Gregory L Kinney  4 , John E Hokanson  4 , Matthew J Budoff  5 , Michael J Cuttica  6 , J Michael Wells  1 , Raúl San José Estépar  2 , George R Washko  2
Affiliations
Multicenter Study

Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease

Surya P Bhatt et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Exacerbation frequency associated with β-blocker use by dichotomized ventricular sizes and dichotomized sphericity indices for right (RV) and left (LV) ventricles. All exacerbation frequencies are expressed as incidence rate ratio (IRR) with 95% confidence intervals. All IRR adjusted for age, sex, race, pack-years of smoking, body mass index, FEV1, percent emphysema on computed tomography, log-transformed coronary artery calcification, presence of coronary artery disease and congestive heart failure, long-acting respiratory medications (long acting β-agonists/inhaled corticosteroids and long-acting antimuscarinics), and the propensity to prescribe β-blocker therapy.
See this image and copyright information in PMC

References

    1. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013;162:237–251. - PubMed
    1. Bhatt SP, Wells JM, Kinney GL, Washko GR, Jr, Budoff M, Kim YI, Bailey WC, Nath H, Hokanson JE, Silverman EK, et al. COPDGene Investigators. β-blockers are associated with a reduction in COPD exacerbations. Thorax. 2016;71:8–14. - PMC - PubMed
    1. Rahaghi FNS-FG, Vegas-Sanchez-Ferrero G, Minhas JK, Come CE, De La Bruere I, Wells JM, González G, Bhatt SP, Fenster BE, Diaz AA, et al. COPDGene Investigators. Ventricular geometry from non-contrast non-ECG-gated CT scans: an imaging marker of cardiopulmonary disease in smokers. Acad Radiol. 2017;24:594–602. - PMC - PubMed
    1. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7:32–43. - PMC - PubMed
    1. Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, et al. COPDGene Investigators; ECLIPSE Study Investigators. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367:913–921. - PMC - PubMed

Publication types

Substances

Associated data